IQE PLC Iqe Plc : Director/Pdmr Shareholding

 
TIDMIQE 
 
 
   28 July 2017 
 
   IQE plc ("IQE" or the "Company") 
 
   Director/PDMR Shareholding 
 
   IQE plc (AIM: IQE) was notified on 25 July 2017 and 27 July 2017 that Dr 
Andrew Nelson, CEO of the Company, sold a total of 5,800,000 ordinary 
shares of 1 pence each in the Company ("Ordinary Shares"), with the two 
sales executed at a gross average price of 106.04 pence per Ordinary 
Share. The Company was also notified on 25 July 2017 that Dr Godfrey 
Ainsworth, Chairman of the Company, sold 1,000,000 Ordinary Shares, with 
the sale executed at a gross average price of 105.14 pence per Ordinary 
Share (together, the "Transactions"). The Transactions were completed on 
25 July 2017 and 27 July 2017. 
 
   Dr Ainsworth accumulated his shareholding exclusively through share 
purchases during the period since the Company's IPO in 1999. Dr Nelson 
accumulated his shareholding through a combination of founder shares, 
share purchases and LTIP awards since the start of the company in 1988. 
These Transactions are for future retirement planning purposes, and in 
the case of Dr Nelson, the sale of shares was made to secure the 
required funds to repay an existing loan which was used to purchase 
shares in the Company. This loan was previously announced on 14 October 
2014 and the loan is due to repayment on 10 October 2017. It is Dr 
Nelson's intention that he will repay the existing loan ahead of the 
repayment date and a further announcement will be made in due course 
upon repayment of this loan. Dr Nelson and Dr Ainsworth remain fully 
committed to the Company and have no plans to sell any further shares at 
this time. 
 
   Post the Transactions, Dr Nelson's total holding comprises of 29,459,218 
Ordinary Shares (which includes 18 million shares that are subject to an 
obligation to repurchase as part of a loan agreement announced on 13(th) 
November 2014), representing 4.31% of the Company's issued share capital, 
and 3,145,433 unexercised fully vested options over Ordinary Shares. Dr 
Ainsworth's total remaining holding comprises of 2,154,197 Ordinary 
Shares, representing 0.32% of the Company's issued share capital. In 
addition, Dr Nelson has 7,532,962 share options, which vest in January 
2019 subject to performance criteria. 
 
   The notification set out below is provided in accordance with the 
requirements of the EU Market Abuse Regulation. 
 
   Notification of a Transaction pursuant to Article 19(1) of Regulation 
(EU) No. 596/2014 
 
 
 
 
1.  Details of the Person discharging managerial responsibilities 
     ("PDMR") / person closely associated with them ("PCA") 
a)  Name                        Dr Andrew Nelson 
2.  Reason for the notification 
a)  Position / status           PDMR (CEO) 
b)  Initial notification /      Initial notification 
    amendment 
3.  Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                        IQE plc 
b)  Legal Entity Identifier     213800Y33WHD3ESJJP16 
4.  Details of the transaction(s): section to be repeated 
     for (i) each type of instrument; (ii) each type of 
     transaction; (iii) each date; and (iv) each place 
     where transactions have been conducted 
a)  Description of the          Ordinary shares of 1 pence each in the Company 
    financial instrument         GB0009619924 
b)  Nature of the transaction   Sale of Ordinary Shares 
c)  Price(s) and volume(s) 
                                 Price(s) Volume(s) 
                                 105.14 pence 5,000,000 Ordinary Shares 
                                 111.66 pence 800,000 Ordinary Shares 
d)  Aggregated information 
     --    Aggregated volume      5,800,000 Ordinary Shares 
                                  106.04 pence per Ordinary Share 
     --    Aggregated price       Total consideration of GBP6,150,345.40 
 
     --    Aggregated total 
e)  Date of the transaction(s)  25 July 2017 and 27 July 2017 
f)  Place of the transaction    London Stock Exchange, AIM 
 
 
 
 
 
 
 
1.  Details of the Person discharging managerial responsibilities 
     ("PDMR") / person closely associated with them ("PCA") 
a)  Name                        Dr Godfrey Ainsworth 
2.  Reason for the notification 
a)  Position / status           PDMR (Chairman) 
b)  Initial notification /      Initial notification 
    amendment 
3.  Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                        IQE plc 
b)  Legal Entity Identifier     213800Y33WHD3ESJJP16 
4.  Details of the transaction(s): section to be repeated 
     for (i) each type of instrument; (ii) each type of 
     transaction; (iii) each date; and (iv) each place 
     where transactions have been conducted 
a)  Description of the          Ordinary shares of 1 pence each in the Company 
    financial instrument         GB0009619924 
b)  Nature of the transaction   Sale of Ordinary Shares 
c)  Price(s) and volume(s) 
                                  Price(s) Volume(s) 
                                  105.14 pence 1,000,000 Ordinary Shares 
d)  Aggregated information 
     --    Aggregated volume      1,000,000 Ordinary Shares 
                                  105.14 pence per Ordinary Share 
     --    Aggregated price       Total consideration of GBP1,051,411.00 
 
     --    Aggregated total 
e)  Date of the transaction     25 July 2017 
f)  Place of the transaction    London Stock Exchange, AIM 
 
 
 
 
   Contacts: 
 
 
 
 
IQE plc 
 Drew Nelson 
 Phil Rasmussen 
 Chris Meadows                [phone] 
Canaccord Genuity 
 Simon Bridges 
 Henry Fitzgerald-O'Connor 
 Richard Andrews             + 44 (0) 20 7523 8000 
Peel Hunt 
 Euan Brown                   [phone] 
 
 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: IQE plc via Globenewswire 
 
 
  http://www.iqep.com 
 

(END) Dow Jones Newswires

July 28, 2017 09:27 ET (13:27 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.